150
Participants
Start Date
November 30, 2006
Primary Completion Date
March 31, 2008
Study Completion Date
April 30, 2008
C105
The Jacobs Neurological Institute, Buffalo
Raleigh Neurology Associates, Raleigh
University of Virginia, Department of Neurology, Charlottesville
Neurological Associates, Inc, Richmond
Capitol Neurology, Charleston
Shepard Center, Atlanta
Neurology Associates, PA, Maitland
Axiom Clinical Research of Florida, Tampa
Suncoast Neuroscience Associates, Inc., St. Petersburg
Lovelace Scientific Resources, Sarasota
Roskamp Institute, Sarasota
University of Kentucky, Lexington
Neurology & Neuroscience Associates, Inc., Akron
Riverhills Healthcare, Inc, Cincinnati
Henry Ford Health System, Department of Neurology, Detroit
Northern Michigan Neurology, Traverse City
MeritCare Neuroscience Clinic, Fargo
University of Kansas Medical Center, Department of Neurology, Kansas City
MidAmerica Neuroscience Institute, Lenexa
Baylor College of Medicine, Houston
Integra Clinical Research, San Antonio
Central Texas Neurology, Round Rock
Saint Joseph's Hospital, Barrow Neurology Clinics, Phoenix
Northwest Neuro Specialists, PLLC, Tuscon
Loma Linda University, Department of Neurology, Loma Linda
Research Center for Clinical Studies West, Lancaster
Associated Neurologists, P.C., Danbury
Associated Neurologist of Southern Connecticut, PC, Fairfield
Yale University MS Center, New Haven
The Neurology Foundation, Inc., Providence
Lead Sponsor
Cognition Pharmaceuticals, LLC
INDUSTRY